Subscribe To

Price Alert Latest News Economic Calendar News

EDXC / Endexx says it is positioned for more growth after doubling 2022 revenue

ENDEXX Corp. (OTC:EDXC) has reported a near doubling in fiscal 2022 revenue and said growth in the year ahead will be supported by a recent restructuring aimed at optimizing its growth potential and expanding its product offerings internationally. The provider of innovative hemp-derived wellness and nutritional products showed a 96% increase in top-line revenue to $1.28 million for the year to September 30, 2022 and generated a gross profit of $503,009 compared to a loss of $344,078 in the prior year. Read More

Demo Live Account See Partner Details

Content Topics

Endexx

Says

Positioned

Growth

After

Doubling

2022

Revenue

Stock

EDXC

Posted: Jan 17 2023, 10:12

Author Name: Proactive Investors

EDXC News

By Proactive Investors
July 5, 2023

No menthol, no problem: flavor bans create opportunities for no-nicotine alternatives

The prohibition of flavored cigarettes, cigars, and vapes in the United States is creating an opportunity for companies producing no-nicotine alternat

By Proactive Investors
June 15, 2023

Endexx division HYLA secures distribution deal for ‘no nicotine' vape products in the Middle East

Endexx said its HYLA division has entered into an eight-country distribution agreement for its “no nicotine” vape products in the Middle East with

By Proactive Investors
June 12, 2023

Endexx reports 2022 profit and revenue surge fueled by Hyla acquisition

Endexx Corp. announced that it swung to a profit in the 2022 financial year driven by its acquisition of a 51% controlling interest in Hyla US, reduce

By Proactive Investors
May 23, 2023

Endexx reports jump in revenues boosted by the acquisition of Hyla

Endexx Corp. (OTC:EDXC) has reported a jump in revenues for the second quarter and the first half of its current financial year, boosted by the acqui

By Proactive Investors
March 15, 2023

Endexx inks $1M plus purchase order for HYLA products in Egypt

Endexx Corp. has announced that its HYLA team has secured a distribution agreement and purchase order contract for the sale of its vape products in Eg

By Proactive Investors
March 1, 2023

Endexx reports 17% increase in 1Q revenues on higher CBD wellness and Skincare sales

ENDEXX Corp. (OTC:EDXC) told investors it continues to grow its CBD wellness and Skincare revenues despite supply chain issues that continue to impact

By Proactive Investors
January 17, 2023

Endexx says it is positioned for more growth after doubling 2022 revenue

ENDEXX Corp. (OTC:EDXC) has reported a near doubling in fiscal 2022 revenue and said growth in the year ahead will be supported by a recent restructur

By GlobeNewsWire
December 7, 2022

Endexx to Present at Sequire Virtual Small Cap Conference on December 8th, 2022

Presentation on Thursday, December 8th, 2022 at 1:00 PM ET

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.